A former Chief Scientist of Israel's Ministry of Health, Prof. Sredni is Director of Bar-Ilan's Cancer, Aids and Immunology Research (CAIR) Institute and a senior member of the Goodman Faculty of Life Sciences. His research is focused on regulation of the immune system by immunomodulators that shift immune responses from Th2 to Th1, and thus, are beneficial in various clinical conditions. In Prof. Sredni's lab, the activities and mechanism of the AS101 immunomodulator were found to exert beneficial effects in the treatment of cancer, as well as several autoimmune and neurodegenerative diseases such as Alzheimer’s, lupus and diabetes. In 2017 Prof. Benjamin Sredni, of the Mina and Everard Goodman Faculty of Life Sciences, has been appointed a lifetime member of the National Academy of Medicine in Mexico. Very few scientists who are academics and live outside of Mexico are awarded this prestigious appointment. The honor was bestowed upon Prof. Sredni at a festive ceremony in Mexico City, where he delivered a lecture in the presence of members of the Academy and the top echelons of the scientific community in Mexico.